La Kedia Charman Banks, NP
Nurse Practitioner · Roseville
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Aleracare Medical Group of California · 9 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call La Kedia Charman Banks’s office at (916) 850-2559 to ask if they take your plan before you enroll.
California Medical Board record
Licence A23015 · Deceased
Licence status: Deceased · since 1968 · University of California, Irvine College of Medicine.
Licensee is deceased.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Money from drug and device companies
$1,008 in 2025
| 2025 | 7 | 8 | None | $1,008 |
| 2024 | 3 | 3 | None | $360 |
| 2023 | 4 | 5 | None | $362 |
| 2022 | 8 | 11 | None | $1,152 |
| 2021 | 1 | 1 | None | $118 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Exelixis | Cabometyx | $245 | 2 payments
|
| Legend Biotech USA | Carvykti | $146 | 1 payment
|
| Pfizer | None | $135 | 1 payment
|
| Janssen Biotech | Tecvayli | $129 | 1 payment
|
| Stemline Therapeutics | Orserdu | $123 | 1 payment
|
| GlaxoSmithKline | Jemperli | $118 | 1 payment
|
See all 8 published payments
| Exelixis | Meals · 2025-11-12 | Cabometyx | $133 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-10-01 | None | $111 |
| GlaxoSmithKline | Meals · 2025-09-10 | Jemperli | $118 |
| Pfizer | Meals · 2025-06-01 | None | $135 |
| Janssen Biotech | Meals · 2025-04-12 | Tecvayli | $129 |
| Stemline Therapeutics | Meals · 2025-03-26 | Orserdu | $123 |
| Legend Biotech USA | Meals · 2025-03-12 | Carvykti | $146 |
| Exelixis | Meals · 2025-02-12 | Cabometyx | $112 |
See earlier years (2024, 2023, 2022, 2021)
2024: $360
| Exelixis | Cabometyx | $129 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Iclusig | $122 | 1 payment
|
| Pfizer | Talzenna | $109 | 1 payment
|
2023: $362
| Exelixis | Cabometyx | $139 | 2 payments
|
| Progenics Pharmaceuticals | Pylarify | $121 | 1 payment
|
| Stemline Therapeutics | Orserdu | $75 | 1 payment
|
| Merck Sharp & Dohme | Keytruda | $27 | 1 payment
|
2022: $1,152
| Genentech USA | Tecentriq | $262 | 2 payments
|
| G1 Therapeutics | Cosela | $249 | 2 payments
|
| E.R. Squibb & Sons L.L.C. | Opdivo | $145 | 2 payments
|
| AVEO Pharmaceuticals | Fotivda | $125 | 1 payment
|
| Daiichi Sankyo | None | $116 | 1 payment
|
| Kyowa Kirin | Poteligeo | $113 | 1 payment
|
| Genzyme | None | $93 | 1 payment
|
| EMD Serono | Bavencio | $50 | 1 payment
|
2021: $118
| Genzyme | Libtayo | $118 | 1 payment
|
Professional record
- NPI
- 1023377231
- Licence
- AL 1-115189, CA 23015, CA 840790California A23015: Deceased
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LF0000X (363LF0000X); Federal specialty code 163W00000X (163W00000X); Federal specialty code 163WC0200X (163WC0200X)
- Mailing address
- 104 Maple Ln, East Palo Alto, CA, 94303
- NPI first listed
- 2012-05-08
- NPI last updated
- 2017-01-04
This is when the NPI record was last certified, not a medical board exam.